PROteolysis TArgeting Chimera (PROTAC) Estrogen Receptor Degraders for Treatment of Estrogen Receptor-Positive Advanced Breast Cancer

The authors describe the unique mechanisms of action of a new class of drugs called PROteolysis TArgeting Chimera estrogen receptor degraders.